Stay updated on Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is displayed, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:43:48.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:44.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no changes to study details or other visible content.
    Difference
    0.1%
    Check dated 2026-03-11T14:43:15.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the previous funding-notice banner and Revision: v3.4.1 banner; changes affect only site-wide notices rather than the study page content.
    Difference
    0.4%
    Check dated 2026-02-11T02:20:04.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Added a global funding-status notice and a page version update (v3.4.1); these changes do not alter the study content or its core functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:01:09.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated the QC-related label to 'Last Update Submitted that Met QC Criteria' and added 'No FEAR Act Data' with the site revision 'v3.4.0'. Removed the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-27T21:26:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Docetaxel in NSCLC: Clinical Trial page.